Simple Summary Prostate cancer affects men of all racial and ethnic groups and leads to
higher rates of mortality in those belonging to a lower socioeconomic status due to late …

Abstract In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee
began the process of a complete update of recommendations for early prostate cancer …

Purpose Active surveillance is increasingly accepted as a treatment option for favorable-risk
prostate cancer. Long-term follow-up has been lacking. In this study, we report the long-term …

Context The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …

Purpose We assessed the outcome of a watchful-waiting protocol with selective delayed
intervention by using clinical prostate-specific antigen (PSA), or histologic progression as …

Purpose We assessed outcomes of men with prostate cancer enrolled in active surveillance.
Patients and Methods Since 1995, a total of 769 men diagnosed with prostate cancer have …

Prostate cancer remains one of the most commonly diagnosed malignancies worldwide.
Early diagnosis and curative treatment seem to improve survival in men with unfavourable …

The field of prostate cancer has been the subject of extensive research that has resulted in
important discoveries and shaped our appreciation of this disease and its management …

Purpose Early intervention for prostate cancer is associated with excellent long-term
survival, but many affected men, especially those with low-risk disease characteristics, might …

Active surveillance (AS) has been introduced as an observational strategy to delay or avoid
curative treatment without compromising long‐term cancer‐specific survival. The 10 studies …